
Current Price | $1.28 | Mkt Cap | $949,800.00 |
---|---|---|---|
Open | $1.26 | P/E Ratio | -0.02 |
Prev. Close | $1.28 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $1.25 - $1.31 | Volume | 144,539 |
52-Wk Range | $1.22 - $43.96 | Avg. Daily Vol. | 840,001 |
A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases.
Current Price | $1.28 | Mkt Cap | $949,800.00 |
---|---|---|---|
Open | $1.26 | P/E Ratio | -0.02 |
Prev. Close | $1.28 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $1.25 - $1.31 | Volume | 144,539 |
52-Wk Range | $1.22 - $43.96 | Avg. Daily Vol. | 840,001 |
The best Bull and Bear pitches based on recency and number of recommendations.
Valuation already anticipates slow launch for Surfaxin (infant respiratory distress syndrome or RDS), but is missing the game changer development of Aerosurf (aerosolized inhalation, also for infant RDS, but avoids the intubation required for… More
History always seems to repeats itself...
Read the most recent pitches from players about WINT.
Recs
shooting to the moon
Recs
The biotechnology field is on the rise. Big things are to come.
Recs
Valuation already anticipates slow launch for Surfaxin (infant respiratory distress syndrome or RDS), but is missing the game changer development of Aerosurf (aerosolized inhalation, also for infant RDS, but avoids the intubation required for Surfaxin and all competition). Recent financing extends cash runwat through Surfaxin launch and aerosurf 2b studies in mid 15. Attractive target.
Find the members with the highest scoring picks in WINT.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
DeadmanLiving | 74.01 |
|
![]() |
1Y | $470.61 | -99.73% | +401.18% | +500.91 | 0 Comment | |
anticitradeshort | 27.28 | 9/30/2009 |
![]() |
NS | $342.30 | -99.63% | +292.38% | +392.01 | 0 Comment | |
californiasun | < 20 | 8/24/2011 |
![]() |
3W | $27.86 | -95.41% | +259.16% | +354.56 | 1 Comment | |
bioman100 | < 20 | 8/25/2006 |
![]() |
NS | $373.80 | -99.66% | +243.36% | +343.02 | 1 Comment | |
IdahoInvestor | 27.58 | 12/16/2011 |
![]() |
5Y | $21.04 | -93.91% | +242.49% | +336.40 | 0 Comment | |
HunterNumber9 | 76.26 | 12/30/2010 |
![]() |
5Y | $52.78 | -97.57% | +231.75% | +329.32 | 0 Comment | |
mjb1977 | 55.82 | 12/29/2010 |
![]() |
5Y | $53.20 | -97.59% | +230.80% | +328.40 | 0 Comment | |
leemanschmidt | 94.47 | 10/12/2006 |
![]() |
3W | $514.52 | -99.75% | +225.52% | +325.27 | 0 Comment | |
Sillitoe | < 20 | 2/11/2008 |
![]() |
NS | $495.60 | -99.74% | +224.60% | +324.34 | 0 Comment | |
Sempre57 | 56.10 | 11/17/2006 |
![]() |
3M | $482.98 | -99.73% | +216.73% | +316.47 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.